Table 1 Baseline characteristics of subjects diagnosed with early HMS (e-HMS), with follow-up (Follow up) versus lost to follow up (Lost)
Characteristic | All (n = 126) | Follow up (n = 81) | Lost (n = 45) | p value |
|---|---|---|---|---|
Age, years [median (IQ range)] | 53.7 (38.9–61.4) | 53.4 (38.9–60.9) | 55.9 (41.5–62.7) | 0.485 |
Gender (F/M) | 52/74 | 31/50 | 21/24 | 0.359 |
Ethnicity (Caucasian/other) | 97/29 | 62/19 | 35/10 | 0.875 |
Exposure, years [median (IQ range)] | 20.0 (11.5–29.5) | 20.0 (12.5–28.5) | 19.5 (10.0–31.0) | 0.839 |
Presence of symptoms, Y/N | 114/10 | 74/6 | 40/4 | 0.742 |
Spleen diameter, cm [median (IQ range)] | 14.0 (13.0–15. 0) | 14.0 (13.0–15. 0) | 13.5 (12.9–15.0) | 0.083 |
Presence of hepatomegaly, Y/N | 43/81 | 30/50 | 13/31 | 0.373 |
Hb, mg/dL [median (IQ range)] | 12.4 (11.0–13.9) | 12.3 (11.0–13.3) | 12.75 (11.0–15.2) | 0.264 |
RBC × 106/µL [median (IQ range)] | 4.2 (3.7–4.7) | 4.1 (3.7–4.7) | 4.5 (3.7–5.0) | 0.233 |
Plt × 103/µL [median (IQ range)] | 173.0 (135.0–228.0) | 170.0 (137.0–217.0) | 179.0 (127.0–259.0) | 0.367 |
ESR, mm/h [median (IQ range)] | 26.0 (12.0–50.0) | 25.0 (14.0–47.0) | 28.0 (9.0–56.0) | 0.892 |
IgM, g/L [median (IQ range)] | 2.8 (1.9–3.7) | 2.9 (1.9–3.8) | 2.8 (1.9–3.6) | 0.727 |
Plasmodium in blood, Y/N | 36/51 | 26/33 | 10/18 | 0.460 |